28.38
1.58 (5.9%)
1.58 (5.9%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NantKwest Inc | NK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.58 | 5.9% | 28.38 | 19:58:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.95 | 26.50 | 30.32 | 28.28 | 26.80 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 28.30 | 29.60 | 1.30 | - | 3 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,838 | 1,296,952 | $ 28.97 | $ 37,574,048 | 3,494,200 | 2.52 - 45.42 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:17 | formt | 500 | $ 28.38 | USD |
NantKwest Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.09B | 108.73M | 38.71M | $ 43.00k | $ - | -0.71 | -23.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
NantKwest News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 33.23 | 34.617 | 23.15 | 27.67 | 1,320,959 | -4.85 | -14.6% |
| 1 Month | 24.00 | 45.42 | 23.15 | 33.02 | 1,689,306 | 4.38 | 18.25% |
| 3 Months | 12.37 | 45.42 | 10.21 | 20.17 | 2,504,750 | 16.01 | 129.43% |
| 6 Months | 6.22 | 45.42 | 6.09 | 16.30 | 1,712,498 | 22.16 | 356.27% |
| 1 Year | 4.41 | 45.42 | 2.52 | 12.18 | 1,734,119 | 23.97 | 543.54% |
| 3 Years | 4.65 | 45.42 | 0.93 | 9.05 | 944,344 | 23.73 | 510.32% |
| 5 Years | 9.61 | 45.42 | 0.93 | 8.49 | 692,400 | 18.77 | 195.32% |
NantKwest Description
| NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories. |
